The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Froimson Mark since 2017.
This trader's CIK number is 1709050.
At the time of last reporting, Froimson Mark was the Director of Pacira Biosciences, Inc.. (stock ticker symbol PCRX).
Also see all insider trading activities at Pacira Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | PCRX | 1,400 | $16,212 | 0 | $0 | 0 | $0 |
| 2022 | PCRX | 0 | $0 | 1,000 | $59,370 | 0 | $0 |
| 2021 | PCRX | 0 | $0 | 734 | $53,038 | 0 | $0 |
| 2017 | PCRX | 100 | $3,713 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-12 | PCRX | Buy | 1,400 | 11.58 | 16,212 |
| 2022-05-09 | PCRX | Sale | 1,000 | 59.37 | 59,370 |
| 2021-03-15 | PCRX | Sale | 734 | 72.26 | 53,038 |
| 2017-08-08 | PCRX | Buy | 100 | 37.13 | 3,713 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Froimson Mark (Director of Pacira Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.